ID W5MEK5_LEPOC Unreviewed; 1462 AA.
AC W5MEK5;
DT 16-APR-2014, integrated into UniProtKB/TrEMBL.
DT 16-APR-2014, sequence version 1.
DT 27-MAR-2024, entry version 47.
DE SubName: Full=Myomesin 3 {ECO:0000313|Ensembl:ENSLOCP00000006814.1};
GN Name=MYOM3 {ECO:0000313|Ensembl:ENSLOCP00000006814.1};
OS Lepisosteus oculatus (Spotted gar).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Actinopterygii; Neopterygii; Holostei; Semionotiformes; Lepisosteidae;
OC Lepisosteus.
OX NCBI_TaxID=7918 {ECO:0000313|Ensembl:ENSLOCP00000006814.1, ECO:0000313|Proteomes:UP000018468};
RN [1] {ECO:0000313|Proteomes:UP000018468}
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA Di Palma F., Alfoldi J., Johnson J., Berlin A., Gnerre S., Jaffe D.,
RA MacCallum I., Young S., Walker B.J., Lander E.S., Lindblad-Toh K.;
RT "The Draft Genome of Lepisosteus oculatus.";
RL Submitted (DEC-2011) to the EMBL/GenBank/DDBJ databases.
RN [2] {ECO:0000313|Ensembl:ENSLOCP00000006814.1}
RP IDENTIFICATION.
RG Ensembl;
RL Submitted (NOV-2023) to UniProtKB.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AHAT01008032; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AHAT01008033; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AHAT01008034; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR STRING; 7918.ENSLOCP00000006814; -.
DR Ensembl; ENSLOCT00000006822.1; ENSLOCP00000006814.1; ENSLOCG00000005636.1.
DR eggNOG; ENOG502RDUJ; Eukaryota.
DR GeneTree; ENSGT00940000158669; -.
DR InParanoid; W5MEK5; -.
DR OMA; VTNTNKD; -.
DR Proteomes; UP000018468; Linkage group LG6.
DR Bgee; ENSLOCG00000005636; Expressed in heart and 5 other cell types or tissues.
DR CDD; cd00063; FN3; 5.
DR CDD; cd00096; Ig; 1.
DR Gene3D; 2.60.40.10; Immunoglobulins; 12.
DR InterPro; IPR003961; FN3_dom.
DR InterPro; IPR036116; FN3_sf.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR013098; Ig_I-set.
DR InterPro; IPR003599; Ig_sub.
DR InterPro; IPR003598; Ig_sub2.
DR PANTHER; PTHR13817:SF151; BENT, ISOFORM F; 1.
DR PANTHER; PTHR13817; TITIN; 1.
DR Pfam; PF00041; fn3; 5.
DR Pfam; PF07679; I-set; 4.
DR PRINTS; PR00014; FNTYPEIII.
DR SMART; SM00060; FN3; 5.
DR SMART; SM00409; IG; 5.
DR SMART; SM00408; IGc2; 4.
DR SUPFAM; SSF49265; Fibronectin type III; 3.
DR SUPFAM; SSF48726; Immunoglobulin; 5.
DR PROSITE; PS50853; FN3; 5.
DR PROSITE; PS50835; IG_LIKE; 4.
PE 4: Predicted;
KW Immunoglobulin domain {ECO:0000256|ARBA:ARBA00023319};
KW Reference proteome {ECO:0000313|Proteomes:UP000018468};
KW Repeat {ECO:0000256|ARBA:ARBA00022737}.
FT DOMAIN 139..233
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 248..330
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 361..457
FT /note="Fibronectin type-III"
FT /evidence="ECO:0000259|PROSITE:PS50853"
FT DOMAIN 489..584
FT /note="Fibronectin type-III"
FT /evidence="ECO:0000259|PROSITE:PS50853"
FT DOMAIN 589..683
FT /note="Fibronectin type-III"
FT /evidence="ECO:0000259|PROSITE:PS50853"
FT DOMAIN 686..784
FT /note="Fibronectin type-III"
FT /evidence="ECO:0000259|PROSITE:PS50853"
FT DOMAIN 791..891
FT /note="Fibronectin type-III"
FT /evidence="ECO:0000259|PROSITE:PS50853"
FT DOMAIN 1145..1225
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 1372..1447
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT REGION 1..36
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 16..30
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1462 AA; 163910 MW; 71B452A362968636 CRC64;
MASKTLIHHT QEEQSDQMFH SLQTSSTTTK KKFKSSDEEV TYQEFHPFVS PEVMSMKELL
NFGASSRSKP WEYMATAEER QEREKRTLFG NEVEKLEVAV ILDQRIMRRR VDRKALRRKA
QEKAMVQKNI LELRKMRPPD FLIPLRSHSV WEQMDVKLSC TVQGCPEPEV TWYKDGIPLQ
RSSLQPWKHK IQKMYGLHTL EIKRCTPDDS GEYRIVITSC LGTASSYAMV FVNSCHGPQS
GYDHTQAPIA ASEKEADFEA AFKPSFAKEG EAFTLSCGFS SALLAHQRGI TWLRDGVPLK
ESEGIEINTG PSATTLTVKE MHKEHEGVYT ICLPAASGVK EHSAYIYVKD AAAAVVGAPG
SPLSVECRDV HKDYVFVTWT PPSADGGGPV FGYYIDRCDV ETGEWVQCNE TPHKFCRYPV
FGLLDGKSYL FRVRAVNNAG IGRPSKSSNP VTMTDPAEAS RIMVVKLDKG KEIIITKDEL
EADILVPLPP TGVHASESSE SYVILSWAEP DPRGREHLSY YIEQSVAGSN SWMMSNLDIP
VNSPRFPVFD LQKGRSYLFR VRSVNKYGVS DPSDCSEPIS LKEKTALPPP AHGIVAYRDT
DTSVLLQWEE PKNAQDIIGY YVYSCEAGTD KWLTVNNKPV NGNRFAVHGL TPWKSYVFKV
KSVSAAGSSE YSEQSAPIVV KAAISPPSPP LAIALLNCGS TEMVIGWRAP ARNGGSAIQG
YFLDQMDTSE LVWHEVNVKP TSERVYKVCS LQEGHSYQFR AFAMNIVGIG KPSEPSSPFL
CQEWNMPEPG CPYDVTCREV RRDSLVLLWE KPLYGGHSPI TGYMVEMCEG REPEAEDWKA
VVEKPTVGTY LKVSGLDAGR IYKFRVSAVN SAGVGQPSLP SEEIRAEIKP GVKDIEIGVD
EDGFIFLAFE SPEMNDSSQF IWAKNYRDAI DAGRVKIESK HNRSRLIFTN PSEKDLGLYT
VEISDINDIS SSYAFTEKGN SCYPLVGYST VIGTLLVKGT SSVHGMICLF LLPPDLERLL
KLSWQVRNPL IGLVSGWEVE VFEKGDVRLW LQVEKLSPAA ELRLIFNDQE ITSSPTRKIN
FDRAKGLVEI LIDPFSDANE GSYTAQLKDG RAKNQFTLVL VDDKFRQTLA QAQSKRRDWK
RKCGPYFLEF LSWKVTENCD LHFSCKVTNT KKDTSLKWYK DGTEIPQIEY NPQTGICTLT
IPQVTIKDIG VYKAVLSDDR GEDISTVDLV DQEFEKLQQE LCRQCALSAG PLEVQPTAEG
FKLYCSLKYY LDYMKTSWYF KEKKLGSEAR TQAGSSMNKV WLEIFNPTES DRGKYTLEMF
DGRDPHRRTL DLSGQVFADA LMEHQRLKQA AIAEKNRARV TKGLPDVVAI MENKSLCLTC
FTAGDPTPEV FWMKNEREIV TGEQYKITTS AGCSSITINQ VTAEDSGKYS IFVRNKHGTQ
TEDVTVSVYK YGEKPSAGAL EM
//
